Joseph Newman

2.4k total citations · 1 hit paper
55 papers, 1.0k citations indexed

About

Joseph Newman is a scholar working on Molecular Biology, Molecular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Joseph Newman has authored 55 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 13 papers in Molecular Medicine and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Joseph Newman's work include Antibiotic Resistance in Bacteria (13 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers) and Cancer therapeutics and mechanisms (8 papers). Joseph Newman is often cited by papers focused on Antibiotic Resistance in Bacteria (13 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers) and Cancer therapeutics and mechanisms (8 papers). Joseph Newman collaborates with scholars based in United States, United Kingdom and Russia. Joseph Newman's co-authors include David B. Schauer, Takeo Kosaka, Barbara J. Sheppard, James G. Fox, A G Vallon, A S Mee, Sharda Jha, Brian A. Zabel, Larry Tsai and Jian Zhou and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Joseph Newman

50 papers receiving 978 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitation

2023 80 citations Sally Singh, Molly M Baldwin et al. The Lancet Respiratory Medicine profile →

Peers

Countries citing papers authored by Joseph Newman

Since Specialization

Citations

This map shows the geographic impact of Joseph Newman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Newman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Newman more than expected).

Fields of papers citing papers by Joseph Newman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Newman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Newman. The network helps show where Joseph Newman may publish in the future.

Co-authorship network of co-authors of Joseph Newman

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Newman. A scholar is included among the top collaborators of Joseph Newman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Newman. Joseph Newman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	The Pulmonary Hypertension Global Patient Survey: understanding the experiences and perspectives of patients	ERJ Open Research	Joseph Newman, Hakim Ghani et al.	0
2	Longer term post-hospital morbidity and mortality following admission with COVID-19: a systematic review and meta-analysis	ERJ Open Research	Joseph Newman, Luke Flower et al.	0
3	First-in-human phase 1/2 study (MYCHELANGELO I) of first-in-class epigenomic controller OTX-2002 targeting MYC oncogene in patients with hepatocellular carcinoma (HCC) and other solid tumors.	Journal of Clinical Oncology	Jonathan Mizrahi, William Senapedis et al.	2
4	Selection of patient-reported outcome measures in pulmonary arterial hypertension clinical trials: a systematic review, meta-analysis and health-related quality of life framework	European Respiratory Review	Joseph Newman, Gregg H. Rawlings et al.	0
5	Associate Principal Investigators and the HEAL-COVID trial: good for trainees, good for trials	Trials	Joseph Newman, Philipp S. Wild et al.	1
6	StratosPHere 2: study protocol for a response-adaptive randomised placebo-controlled phase II trial to evaluate hydroxychloroquine and phenylbutyrate in pulmonary arterial hypertension caused by mutations in BMPR2	Trials	Nina Deliu, Joseph Newman et al.	6
7	Shorter walk test durations to detect ambulatory oxygen desaturation in interstitial lung disease: an observational cohort study	ERJ Open Research	Karl Sylvester, Joseph Newman et al.	1
8	Pulmonary Hypertension International Survey of Health Impacts (PHISH): a global patient questionnaire		Joseph Newman, Millicent Stone et al.	1
9	Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitation breakdown →	The Lancet Respiratory Medicine	Sally Singh, Molly M Baldwin et al.	80
10	Rising COVID-19 related acute pulmonary emboli but falling national chronic thromboembolic pulmonary hypertension referrals from a large national dataset	ERJ Open Research	Joseph Newman, David P. Jenkins et al.	9
11	Loperamide: an emerging drug of abuse and cause of prolonged QTc	Clinical Medicine	Joseph Newman et al.	8
12	Medical students on the hospital ward: what do patients really think?	Future Healthcare Journal	Joseph Newman, Bimbi Fernando et al.	2
13	Secreted Gaussia princeps Luciferase as a Reporter of Escherichia coli Replication in a Mouse Tissue Cage Model of Infection	PLoS ONE	Mingyu Liu, Sarah M. McLeod et al.	9
14	Antibacterial Inhibitors of Gram-Positive Thymidylate Kinase: Structure–Activity Relationships and Chiral Preference of a New Hydrophobic Binding Region	Journal of Medicinal Chemistry	Sameer Kawatkar, Thomas A. Keating et al.	49
15	Novel Bacterial NAD ⁺ -Dependent DNA Ligase Inhibitors with Broad-Spectrum Activity and Antibacterial Efficacy In Vivo	Antimicrobial Agents and Chemotherapy	Scott D. Mills, Ann E. Eakin et al.	63
16	Managing Complex Augmented Reality Models	IEEE Computer Graphics and Applications	Dieter Schmalstieg, Gerhard Schall et al.	28
17	A path from primary protein sequence to ligand recognition	Proteins Structure Function and Bioinformatics	Joseph Newman, Richard M. Jack et al.	12
18	Bacterial Infection Promotes Colon Tumorigenesis in Apc ^Min/+ Mice	The Journal of Infectious Diseases	Joseph Newman, Takeo Kosaka et al.	117
19	EnteropathogenicEscherichia coliand Ulcerative Colitis in Cotton‐Top Tamarins(Saguinus oedipus)	The Journal of Infectious Diseases	Keith G. Mansfield, Joseph Newman et al.	31
20	Small bowel biopsy for malabsorption: comparison of the diagnostic adequacy of endoscopic forceps and capsule biopsy specimens.	BMJ	A S Mee, A G Vallon et al.	74

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact